BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank71
3Y CAGR-11.7%
5Y CAGR+2.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-11.7%/yr
vs +33.8%/yr prior
5Y CAGR
+2.1%/yr
Recent deceleration
Acceleration
-45.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.93 | -45.9% |
| 2024 | 1.72 | +7.5% |
| 2023 | 1.60 | +18.4% |
| 2022 | 1.35 | +33.7% |
| 2021 | 1.01 | +20.8% |
| 2020 | 0.84 | +72.9% |
| 2019 | 0.48 | +14.7% |
| 2018 | 0.42 | +37.1% |
| 2017 | 0.31 | -48.7% |
| 2016 | 0.60 | - |